Friedrich MG - Search Results

1

[DNA methylation on urinalysis and as a prognostic marker in urothelial cancer of the bladder].

Friedrich MG, Toma MI, Chun JK, Steuber T, Budäus L, Isbarn H, Huland H. Friedrich MG, et al. Urologe A. 2007 Jul;46(7):761-8. doi: 10.1007/s00120-007-1360-3. Urologe A. 2007. PMID: 17522834 German.

2

Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.

Friedrich MG, Chandrasoma S, Siegmund KD, Weisenberger DJ, Cheng JC, Toma MI, Huland H, Jones PA, Liang G. Friedrich MG, et al. Eur J Cancer. 2005 Nov;41(17):2769-78. doi: 10.1016/j.ejca.2005.07.019. Epub 2005 Oct 19. Eur J Cancer. 2005. PMID: 16242928

3

Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours.

Hellwinkel OJ, Kedia M, Isbarn H, Budäus L, Friedrich MG. Hellwinkel OJ, et al. Among authors: friedrich mg. BJU Int. 2008 Mar;101(6):753-7. doi: 10.1111/j.1464-410X.2007.07322.x. Epub 2007 Dec 7. BJU Int. 2008. PMID: 18070176

4

[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers].

Hautmann SH, Schroeder GL, Civantos F, Duncan RC, Gnann R, Friedrich MG, Hellstern A, Huland H, Soloway MS, Lokeshwar VB. Hautmann SH, et al. Among authors: friedrich mg. Urologe A. 2001 Mar;40(2):121-6. doi: 10.1007/s001200050449. Urologe A. 2001. PMID: 11315586 German.

5

[Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].

Friedrich MG, Hellstern A, Hautmann SH, Noldus I, Huland H. Friedrich MG, et al. Urologe A. 2003 Apr;42(4):523-30. doi: 10.1007/s00120-002-0247-6. Epub 2003 Jan 17. Urologe A. 2003. PMID: 12715124 German.

6

[Cystectomy for indications other than bladder cancer].

Hautmann S, Felix-Chun KH, Currlin E, Friedrich MG, Dose Schwarz J, Langwieler T, Conrad S, Huland H. Hautmann S, et al. Among authors: friedrich mg. Urologe A. 2004 Feb;43(2):172-7. doi: 10.1007/s00120-003-0485-2. Urologe A. 2004. PMID: 14991119 Clinical Trial. German.

7

[Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder].

Isbarn H, Budäus L, Pichlmeier U, Conrad S, Huland H, Friedrich MG. Isbarn H, et al. Among authors: friedrich mg. Urologe A. 2008 May;47(5):608-15. doi: 10.1007/s00120-008-1671-z. Urologe A. 2008. PMID: 18317718 Clinical Trial. German.

8

Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?

Friedrich MG, Hellstern A, Toma MI, Hammerer P, Huland H. Friedrich MG, et al. Eur Urol. 2003 Feb;43(2):146-50; discussion 150-1. doi: 10.1016/s0302-2838(02)00555-9. Eur Urol. 2003. PMID: 12565772

9

Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer.

Toma MI, Friedrich MG, Hautmann SH, Jäkel KT, Erbersdobler A, Hellstern A, Huland H. Toma MI, et al. Among authors: friedrich mg. World J Urol. 2004 Jun;22(2):145-9. doi: 10.1007/s00345-003-0390-8. Epub 2004 Feb 27. World J Urol. 2004. PMID: 14991320

10

Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.

Friedrich MG, Toma MI, Petri S, Cheng JC, Hammerer P, Erbersdobler A, Huland H. Friedrich MG, et al. Eur Urol. 2004 Jun;45(6):737-43. doi: 10.1016/j.eururo.2003.12.005. Eur Urol. 2004. PMID: 15149745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

336 results

Search Page